Objectives. These guidelines are based on a first edition that was published in 2004, and
have been edited and updated with the available scientific evidence up to October 2012 …

Up to 50 or 60% of patients with chronic epilepsy have various mood disorders including
depression and anxiety. Whereas the relationship between epilepsy and depression has …

Objectives. These guidelines are based on a first edition that was published in 2002, and
have been edited and updated with the available scientific evidence until September 2009 …

Antiepileptic drugs (AEDs) are increasingly used for the treatment of several non‐epileptic
neurological conditions and psychiatric disorders. Most of the information available on the …

Advances made in diverse areas of neuroscience suggest that neurotransmitter systems,
additional to the monoaminergic, contribute to the pathophysiology of mood disorders. This …

Valproate for schizophrenia - Wang, Y - 2016 | Cochrane Library Skip to Content Cookies Our
site uses cookies to improve your experience. You can find out more about our use of cookies …

Objective: Gabapentin is commonly used off-label in the treatment of psychiatric disorders
with success, failure, and controversy. A systematic review of the literature was performed to …

Increasing evidence suggests that abnormalities in amino neurotransmission are associated
with the neurobiology of depression. Preclinical studies demonstrate that GABA modulating …

The anticonvulsant drug Gabapentin (GAB) is used for the treatment of various diseases (eg
epilepsy, bipolar disorder, neuropathic pain) and is being consumed in high amounts. As …

Major depressive disorder (MDD) is a chronic and potentially life threatening illness that
carries a staggering global burden. Characterized by depressed mood, MDD is often difficult …